1. Academic Validation
  2. GSK-3β controls autophagy by modulating LKB1-AMPK pathway in prostate cancer cells

GSK-3β controls autophagy by modulating LKB1-AMPK pathway in prostate cancer cells

  • Prostate. 2016 Feb;76(2):172-83. doi: 10.1002/pros.23106.
Aijing Sun 1 2 Changlin Li 2 Ruibao Chen 2 Yiling Huang 2 3 Qi Chen 4 Xiangjun Cui 5 Huafeng Liu 6 J Brantley Thrasher 2 Benyi Li 2 3 5 6
Affiliations

Affiliations

  • 1 Department of Pathology, Shaoxing University School of Medicine, Shaoxing, China.
  • 2 Department of Urology, University of Kansas Medical Center, Kansas City, Kansas.
  • 3 Department of Pathology, China Three Gorges University College of Medicine, Yichang, China.
  • 4 Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas.
  • 5 Department of Clinical Immunology and Rheumatology, Yichang Renmin Hospital, China Three Gorges University, Yichang, China.
  • 6 Department of Internal Medicine and Kidney Institute, The Affiliated Hospital, Guangdong Medical College, Zhanjiang, China.
Abstract

Background: Glycogen synthase kinase 3β (GSK3B, GSK-3β) is a multi-functional protein kinase involved in various cellular processes and its activity elevates after serum deprivation. We have shown that inhibition of GSK-3β activity triggered a profound autophagic response and subsequent necrotic cell death after serum deprivation in prostate Cancer cells. In this study, we dissected the mechanisms involved in GSK-3β inhibition-triggered Autophagy.

Methods: Prostate Cancer PC-3 and DU145 cells were used in the study. Multiple GSK-3β specific inhibitors were used including small chemicals TDZD8, Tideglusib, TWS119, and peptide L803-mts. Western blot assay coupled with phospho-specific Antibodies were used in detecting signal pathway activation. ATP levels were assessed with ATPLite kit and HPLC methods. Autophagy response was determined by evaluating Microtubule-associated proteins 1A/1B LIGHT chain 3B (LC3B) processing and p62 protein stability in Western blot assays. Immunofluorescent microscopy was used to detect LKB1 translocation.

Results: Inhibition of GSK-3β activity resulted in a significant decline of cellular ATP production, leading to a significant increase of AMP/ATP ratio, a strong trigger of AMP-activated protein kinase (AMPK) activation in prostate Cancer PC-3 cells. In parallel with increased LC-3B biosynthesis and p62 protein reduction, the classical sign of Autophagy induction, AMPK was activated after inhibition of GSK-3β activity. Further analysis revealed that Liver kinase B1 (LKB1) but not Calcium/calmodulin-dependent protein kinase kinase β (CaMKKβ) is involved in AMPK activation and Autophagy induction triggered by GSK-3β inhibition. Meanwhile, GSK-3β inhibition promoted LKB1 translocation from nuclear to cytoplasmic compartment and enhanced LKB1 interaction with its regulatory partners Mouse protein-25 (MO25) and STE20-related adaptor (STRAD).

Conclusions: In conclusion, our data suggest that GSK-3β plays an important role in controlling Autophagy induction by modulating the activation of LKB1-AMPK pathway after serum deprivation.

Keywords

AMPK; GSK-3β; LKB1; autophagy; serum deprivation.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-11012
    99.81%, GSK-3 Inhibitor